KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Income from Continuing Operations: 2009-2025

Historic Income from Continuing Operations for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Sep 2025 value amounting to $71.8 million.

  • Acadia Pharmaceuticals' Income from Continuing Operations rose 119.14% to $71.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $261.2 million, marking a year-over-year increase of 103.33%. This contributed to the annual value of $226.5 million for FY2024, which is 469.20% up from last year.
  • Acadia Pharmaceuticals' Income from Continuing Operations amounted to $71.8 million in Q3 2025, which was up 169.26% from $26.7 million recorded in Q2 2025.
  • Over the past 5 years, Acadia Pharmaceuticals' Income from Continuing Operations peaked at $143.8 million during Q4 2024, and registered a low of -$113.1 million during Q1 2022.
  • Moreover, its 3-year median value for Income from Continuing Operations was $26.7 million (2025), whereas its average is $25.7 million.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Income from Continuing Operations slumped by 139.49% in 2023 and then skyrocketed by 2,898.20% in 2024.
  • Over the past 5 years, Acadia Pharmaceuticals' Income from Continuing Operations (Quarterly) stood at -$43.1 million in 2021, then climbed by 3.29% to -$41.7 million in 2022, then skyrocketed by 209.77% to $45.7 million in 2023, then soared by 214.23% to $143.8 million in 2024, then skyrocketed by 119.14% to $71.8 million in 2025.
  • Its Income from Continuing Operations was $71.8 million in Q3 2025, compared to $26.7 million in Q2 2025 and $19.0 million in Q1 2025.